Vasculitis Flashcards
GCA
a) Classic presentation
b) Diagnostic findings
c) Management
d) If steroids cannot be tapered at 12 months, what is most appropriate management?
a) - Aged over 50 (more common in women)
- Unilateral headache of subacute onset
- Scalp tenderness, jaw claudication, vision loss
- Systemic features - fever, weight loss, depression
- PMR in 40% - morning pain + stiffness in shoulder/pelvis
- Other vasculitic features e.g. mononeuritis, skin rash
O/E
- Scalp tenderness (particularly temporal region)
- Reduced or absent temporal artery pulsation
b) - ESR >50 is significant
- Temporal artery US - ‘halo’ sign
- Temporal artery biopsy: Marked intimal thickening, transmural inflammation, T-cell and histiocyte infiltration, multinucleated giant cells present
(note: biopsy may be normal due to skip lesions)
c) Visual symptoms:
- Urgent ophthalmology review and inpatient admission
- 60-100 mg oral prednisolone or 0.5-1g IV methylprednisolone for 3/7 followed by oral pred
No visual symptoms:
- Urgent rheumatology review, probable outpatient treatment
- 40-60mg oral prednisolone daily
Further management:
- Monitoring of clinical situation, and of steroid SEs (hypertension, hyperglycaemia, etc.)
- PPI and bone prophylaxis often given
- Steroid dose gradually tapered down over 12-18 months
d) Continue steroids, consider addition of methotrexate or IL-6 inhibitor (tocilizumab) and then gradually taper steroids
Polyarteritis nodosa
a) Aneurysm appearance
b) Vessel size affected
c) Disease associated
d) Presentation
e) Lab findings
f) Management
a) Rosary bead
Microaneurysms common in angiography
b) Medium sized vessels have aneurysms (classical for PAN)
c) Hep B
d) Skin and neuro commonly
- Livedo reticularis, ulceration
- Mononeuritis multiplex
Fever, myalgia, wt loss, arthralgia, etc.
Renal involvement may cause renal hypertension and AKI but not GN
Does not affect the lungs
Can cause non-atheromatous coronary and gut infarction
e) Neutrophilia
Not ANCA-associated
HBsAg in 30%
f) Steroids
- If Hep B positive, give Interferon
GPA vs EGPA vs MPA
a) Clinical features
b) Histology
c) Antibodies
d) Management
GPA
- Upper resp (sinusitis, nasal), lower resp (SOB, haemoptysis), skin (vasculitis) and renal (RPGN). Not usually history of asthma or eosinophils
- Necrotising granulomatous inflammation
- c-ANCA (PR-3) positive in 90%, MPO positive in 10%
- High dose steroids + cyclophosphamide*. PLEX considered if RPGN or pulmonary haemorrhage
*avoid in women of childbearing age as reduces fertility- substitute with MMF
EGPA:
- Lower resp predominant (asthma), upper resp also (sinusitis), renal involvement in 50% (20% GN), skin, mononeuritis, eosinophilia
- Necrotising granulomatous inflammation
- p-ANCA (Anti-MPO) in 40%, ANCA-negative commonly, very rarely anti-PR3
- 80% respond to steroids, 20% need cytotoxic meds
MPA:
- Smaller vessel disease, affecting kidneys causing GN (90%), nerves (mononeuritis), skin (petechiae, purpurae) commonly.
- Less commonly affects the lungs (10%), rarely affects the upper airways/sinuses
- Non-granulomatous
- Anti-MPO common, less commonly anti-PR3
Takayasu arteritis
a) Epidemiology
b) Arteries affected commonly
c) Clinical features
d) Management
e) Prognosis
a) - Rare
- Most common in Asian (esp Japanese) women 20-40
b) Large vessels:
- Affects aorta and PA, and major branches commonly
- Also known as ‘pulseless disease’
c) - Causes discrepancy in BP between left and right arms, and between UL + LLs
- Causes ischaemic and claudication symptoms
- Causes weight loss, fever, malaise
- Bruits commonly heard
d) - Steroids + other immunosuppressants
- Statins + aspirin may be used
- Surgery e.g. angioplasty/ revascularisation
e) - 98% survival >10 years with treatment, most have monophasic illness and do not recur when steroids tapered over 2-5 years
- Complications include MI, CVA, heart failure, aortic aneurysm rupture
ESR
a) Normal range for men and for women
b) Significant value for GCA
a) Men: age / 2
Women: (age + 10) / 2
i.e.
70 year old man - normal ESR up to 35
70 year old woman: normal ESR up to 40
b) >50 (but may be lower if strong suspicion, or if on steroids/other immunosuppression)
Churg-Strauss diagnostic criteria - HAPPEN
4 out of 6:
Histological evidence of extravascular eosinophils
Asthma
Pulmonary infiltrates
Paranasal sinus abnormalities
Eosinophils >10% WCC differential
Neuropathy - poly or mono